Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2012-08-06

Clinical Trial Update: WEUSKOP6166: Lamotrigine and Aseptic Meningitis

View source ↗

Summary

Clinical trial WEUSKOP6166 studying lamotrigine in epilepsy has an update related to aseptic meningitis risk. The safety signal centers on aseptic meningitis as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED